Dental students in India aware of the risk of occupational HIV exposure and concept of PEP therapy but not aware of how to correctly use it
Continue readingKnowledge, Attitude and Practices toward PEP among Dental Students in India
Post Category → #medicalPapers
Review of Current Evidence Supports Use of PEPSE to Prevent HIV Transmission
Several studies show evidence of the efficiency of Post exposure prophylaxis after sexual exposure to HIV (PEPSE) in preventing HIV.
Continue readingIncentives Increase the use of PEP among Men Having Sex with Men who abuse drugs
Study finds evidence of reduced transmission risk behavior and reduced stimulant use in men who have sex with men through use of incentives
Continue readingFew Medical Students in Developing Countries Aware of HIV Prevention Drugs
Knowledge on PEP among clinical medical students in developing countries is very low calling for inclusion of PEP in HIV curricula.
Continue readingNew Integrase Inhibitors Better In Controlling HIV Replication than Other Antiretrovirals
Availability of new integrase inhibitors offers better opportunities to improve efficiency of cART and PEP in controlling HIV replication.
Continue readingHIV Post-exposure Prophylaxis: Future Research Methodological Challenges and Potential Approaches
Research has played a vital role in changing the face of the medical field. From untreatable diseases to highly contagious diseases, research made wondrous achievements and solved the previously unsolvable. The research on HIV has also provided us with life-saving treatments like a prophylaxis from HIV. The WHO (World Health Organization) convened a meeting in… Continue reading
End users’ perspective of HIV PEP
HIV PEP has been a revolutionary treatment that has prevented many who have been exposed to the HIV virus from getting infected. Information, news, scientific findings, views and recommendations have always been coming from healthcare institutions and scientific bodies, but seldom do we get the chance to know views and experiences of end-users who are prescribing PEP… Continue reading
A systemic review for choice of HIV PEP treatment on Children with HIV exposure
The Human Immunodeficiency Virus (HIV) is not an adult-only disease but is also known to infect infants and children. The common causes of HIV infections in children are usually accidental needle stick injuries, premastication and sexual assault. Guidelines for adults recommend a base of tenofovir with lamivudine (3TC)/emtricitabine (FTC) and a third drug which is either… Continue reading
HIV Pre-exposure Prophylaxis, Post-Exposure Prophylaxis and Early Treatment: An Integration
With advancements in the field of research and scientific probing, we are continuously getting better treatments and vaccinations for different diseases. Although, there are currently no vaccines which can prevent HIV, scientists have been able to formulate the next best thing – HIV Pre-exposure Prophylaxis (PrEP). A report by the Center of Diseases, Control and… Continue reading
Adherence to HIV post-exposure Prophylaxis and its Side Effects: A study from Ghana
HIV holds a great threat to health care workers as constant exposure may lead to accidental HIV infection in previously un-infected individuals. A timely treatment of HIV Post-exposure Prophylaxis (PEP) is a prevention therapy that has been proven to be highly effective in protecting against occupational HIV infection. Due to its potential toxicities though, a… Continue reading